Summary
5.21 0.01(0.19%)09/27/2024
LifeMD Inc (LFMD)
LifeMD Inc (LFMD)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.19 | -1.08 | -30.34 | -9.80 | 61.72 | 220.81 | -87.97 | -86.78 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 5.21 | |
| Open | 5.25 | |
| High | 5.43 | |
| Low | 5.17 | |
| Volume | 332,454 | |
| Change | 0.01 | |
| Change % | 0.19 | |
| Avg Volume (20 Days) | 1,099,918 | |
| Volume/Avg Volume (20 Days) Ratio | 0.30 | |
| 52 Week Range | 1.14 - 9.11 | |
| Price vs 52 Week High | -42.81% | |
| Price vs 52 Week Low | 357.02% | |
| Range | -2.06 | |
| Gap Up/Down | -0.24 | |
Fundamentals | ||
| Market Capitalization (Mln) | 224 | |
| EBIDTA | 0 | |
| PE Ratio | 0.0000 | |
| PEG Ratio | 0.0000 | |
| WallStreet Target Price | 15.50 | |
| Book Value | 0.0000 | |
| Earnings Per Share | -3.1060 | |
| EPS Estimate Current Quarter | -0.6200 | |
| EPS Estimate Next Quarter | -0.5200 | |
| EPS Estimate Current Year | -1.9800 | |
| EPS Estimate Next Year | -1.1400 | |
| Diluted EPS (TTM) | -3.1060 | |
| Revenues | ||
| Profit Marging | -0.9577 | |
| Operating Marging (TTM) | -0.9312 | |
| Return on asset (TTM) | -4.1874 | |
| Return on equity (TTM) | 0.0000 | |
| Revenue TTM | 78,352,472 | |
| Revenue per share TTM | 3.2370 | |
| Quarterly Revenue Growth (YOY) | 1.2670 | |
| Quarterly Earnings Growth (YOY) | 0.0000 | |
| Gross Profit (TTM) | 28,386,468 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 0.0000 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.0000 | |
| Revenue Enterprise Value | 1.7589 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 30,593,300 | |
| Shares Float | 21,999,314 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 29.11 | |
| Institutions (%) | 28.76 | |
09/24 16:05 EST - globenewswire.com
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
09/10 15:44 EST - seekingalpha.com
LifeMD: Selling WorkSimpli Could Be A Catalyst
LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and GLP1 offerings show significant potential, with the stock priced at 14x forward EBITDA. I have revised my price target from $20 to $15 per share by summer 2025, due to management's credibility issues and uncertainties in GLP1 prospects.
LifeMD: Selling WorkSimpli Could Be A Catalyst
LifeMD's Q2 2024 earnings were mixed, with management failing to monetize the non-core WorkSimpli asset, leading me to assign it no value. Despite management's over-promising, LifeMD's telehealth and GLP1 offerings show significant potential, with the stock priced at 14x forward EBITDA. I have revised my price target from $20 to $15 per share by summer 2025, due to management's credibility issues and uncertainties in GLP1 prospects.
08/26 16:05 EST - globenewswire.com
LifeMD to Participate in Three Investor Conferences During September
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September:
LifeMD to Participate in Three Investor Conferences During September
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September:
08/08 23:21 EST - seekingalpha.com
LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Officer Conference Call Participants David Larsen – BTIG Steve Dechert – KeyBanc William Wood – B. Riley Securities Sarah James – Cantor Yi Chen – H.C.
LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Company Participants Justin Schreiber – Chairman and Chief Executive Officer Marc Benathen – Chief Financial Officer Conference Call Participants David Larsen – BTIG Steve Dechert – KeyBanc William Wood – B. Riley Securities Sarah James – Cantor Yi Chen – H.C.
08/07 19:30 EST - zacks.com
LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.23 per share a year ago.
LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.23 per share a year ago.
08/07 16:05 EST - globenewswire.com
LifeMD Reports Second Quarter 2024 Results
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight management subscribers exceeded 60,000 as of June 30, 2024 Adjusted EBITDA increased 44% to $2.5 million Cash of $35.7 million as of June 30, 2024, and positive net cash flow in three of the last four quarters Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three and six months ended June 30, 2024.
LifeMD Reports Second Quarter 2024 Results
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight management subscribers exceeded 60,000 as of June 30, 2024 Adjusted EBITDA increased 44% to $2.5 million Cash of $35.7 million as of June 30, 2024, and positive net cash flow in three of the last four quarters Conference call begins at 4:30 p.m. Eastern time today NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today reported financial results for the three and six months ended June 30, 2024.
07/31 13:07 EST - seekingalpha.com
LifeMD: High Growth GLP-1 Telehealth Play At A Discount
LifeMD is positioned as a high-growth telehealth play with a focus on GLP-1 weight management treatments. The company is guiding for 35% revenue growth in 2024. Its core telehealth business is expected to grow at least 43%. Non-core software subsidiary WorkSimpli may be spun off in the next 6 to 12 months, while the company is on track for GAAP profitability next year.
LifeMD: High Growth GLP-1 Telehealth Play At A Discount
LifeMD is positioned as a high-growth telehealth play with a focus on GLP-1 weight management treatments. The company is guiding for 35% revenue growth in 2024. Its core telehealth business is expected to grow at least 43%. Non-core software subsidiary WorkSimpli may be spun off in the next 6 to 12 months, while the company is on track for GAAP profitability next year.
07/16 07:05 EST - investorplace.com
3 Overlooked Telehealth Stocks Poised for a Comeback
Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.
3 Overlooked Telehealth Stocks Poised for a Comeback
Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.
06/25 16:05 EST - globenewswire.com
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share.
06/10 08:00 EST - globenewswire.com
LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lotte New York Palace. Justin Schreiber, Chief Executive Officer of LifeMD, will be joining a panel discussion titled “Weight Management/Diabetes Care: Tools to Manage Cost vs Benefit.” Management will also be holding one-on-one meetings with investors.
LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lotte New York Palace. Justin Schreiber, Chief Executive Officer of LifeMD, will be joining a panel discussion titled “Weight Management/Diabetes Care: Tools to Manage Cost vs Benefit.” Management will also be holding one-on-one meetings with investors.
05/28 06:06 EST - marketbeat.com
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD Inc. NASDAQ: LFMD is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary care services to consumers.
LifeMD Can Surge on Its GLP-1 Offerings
LifeMD Inc. NASDAQ: LFMD is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary care services to consumers.
05/08 19:42 EST - seekingalpha.com
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor William Wood - B. Riley Securities Alex Fuhrman - Craig-Hallum Operator Good afternoon.
LifeMD, Inc. (LFMD) Q1 2024 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Justin Schreiber - Chairman & Chief Executive Officer Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor William Wood - B. Riley Securities Alex Fuhrman - Craig-Hallum Operator Good afternoon.
05/08 08:45 EST - prnewswire.com
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)
NEW YORK , May 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The investigation seeks to determine whether LifeMD's directors breached their fiduciary duties in connection with recent corporate actions.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of LifeMD, Inc. (NASDAQ: LFMD)
NEW YORK , May 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The investigation seeks to determine whether LifeMD's directors breached their fiduciary duties in connection with recent corporate actions.
05/03 08:26 EST - zacks.com
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
4 Stocks to Keep a Tab on for Amazing Earnings Acceleration
Notable companies to have witnessed solid earnings acceleration as of now are Sana Biotechnology (SANA), LifeMD (LFMD), Evolus (EOLS) and Expro Group Holdings (XPRO).
05/02 08:00 EST - globenewswire.com
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes
LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes
04/29 08:00 EST - globenewswire.com
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors.
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Calum MacRae, M.D., Ph.D., a clinician, researcher and educator at Harvard Medical School, as an independent member of its Board of Directors.
04/24 08:00 EST - globenewswire.com
LifeMD to Report First Quarter 2024 Financial Results on May 8
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.
LifeMD to Report First Quarter 2024 Financial Results on May 8
NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on May 8, 2024 and will host a conference call beginning at 4:30 p.m. Eastern time.
03/25 08:00 EST - globenewswire.com
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needham Virtual Healthcare Conference taking place April 8-11, 2024. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.
LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 23rd Annual Needham Virtual Healthcare Conference taking place April 8-11, 2024. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.
03/19 06:05 EST - marketbeat.com
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD Inc. NASDAQ: LFMD provides telehealth services to consumers in the United States. The medical sector company operates many telehealth brands, including men's telehealth brands RexMD and ShapiroMD, NavaMD female dermatology telehealth, Cleared Allergy Clinic, and LifeMD Primary Care.